Found 6 matching trials
Drug-drug Interaction Study of Gefitinb on Apatinib in NSCLC Patients
PHASE1The primary objective of the study was to assess the effect of gefitinib on...
Location
Sun Yat-Sen Univercity Cancer Center
Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer
PHASE1Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), in...
Location
Peking University Third Hospital
Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC
PHASE2This phase 2 study is designed to evaluate the safety and activity of apati...
Location
Sichuan Cancer Hospital
Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance
PHASE2This is an open-label, multicenter, randomized, phase II clinical trial, wh...
Location
Shanghai Pulmonary Hospital;
Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer
PHASE2Epidermal growth factor receptor Tyrosine kinase inhibitor (EGFR TKI) have ...
A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations
PHASE3The main purpose of this study is to evaluate the safety and efficacy of Ap...
Location
Sun Yat-sen University Cancer Center